Loading organizations...
Mabel Manufacturing provides comprehensive cannabis supply chain solutions, specializing in contract pre-roll production and packaging services. The company offers a range of professional-grade offerings, including expertly manufactured pre-roll joints, blunts, and kief-infused products, along with custom packaging and labeling that ensures regulatory compliance. Their technical approach emphasizes consistent quality and scalable production processes designed to meet the demands of a dynamic market.
The company emerged from over a decade of experience within the evolving cannabis industry, built upon an insight into the critical need for specialized, compliant manufacturing and co-packing partners. Recognizing the complexities of cannabis production and distribution, Mabel Manufacturing positioned itself to offer reliable, high-quality solutions, allowing brands to outsource intricate production processes while maintaining product integrity and market readiness.
Mabel Manufacturing serves leading cannabis brands, acting as a trusted partner in navigating the challenges of product development, manufacturing, and distribution. The company's vision is to empower its clients by providing an all-in-one service that streamlines operations, ensures adherence to state-specific regulations, and consistently delivers premium cannabis products to consumers. They aim to foster brand growth through operational excellence and unwavering quality.
Mabel has raised $2.1M across 2 funding rounds.
Mabel has raised $2.1M in total across 2 funding rounds.
Mabel has raised $2.1M in total across 2 funding rounds.
Mabel's investors include Partech Ventures, Summit Partners, Stephan Dietrich, Incubate Fund, Manu Chandra, Anshu Prasher.
Mabel AI is a technology company developing a real-time AI-powered translation and transcription tool tailored for healthcare and public sector applications. It provides voice-to-voice translation with domain-specific medical vocabulary, running securely on mobile devices, on-premise servers, or dedicated data centers without third-party APIs to ensure confidentiality and HIPAA-level compliance.[2][3]
The product addresses language barriers in critical settings like emergency rooms, enabling seamless communication between healthcare providers and patients with limited English proficiency. It serves hospitals, ambulatory practices, health systems, government entities, and similar organizations, solving miscommunication risks that delay care or endanger lives. While specific growth metrics are limited, its focus on secure, on-premise deployment positions it amid rising demand for AI-driven language tools in regulated industries.[2][3]
Mabel AI originated from real-world challenges in healthcare communication. Co-founder Karolina, a doctor with 15 years of emergency room experience, identified acute language barriers where interpreter shortages caused miscommunication and life-threatening delays.[3]
Meanwhile, co-founder Shahid, with extensive AI expertise from academia and industry, shared these pain points from a technical perspective. Together, they harnessed AI advancements to create secure interpretation solutions without compromising privacy, evolving from an emergency room idea into a multidisciplinary team blending medical, AI, and linguistic backgrounds.[3]
(Note: Search results distinguish Mabel AI from unrelated entities like a small Haifa-based software firm or Mable Technologies in web development.[1][4])
Mabel AI rides the wave of AI language models intersecting with healthcare's push for equitable access amid global migration and aging populations. Timing aligns with post-pandemic telehealth growth and regulations mandating language support, amplifying needs for instant, secure interpretation over traditional on-site or phone services.[2][3]
Market forces like interpreter shortages and rising HIPAA-compliant AI adoption favor on-premise solutions, reducing latency and breach risks compared to cloud-based rivals. By enabling "good communication" as the foundation of care, Mabel influences the ecosystem toward inclusive tech, potentially setting standards for AI in sensitive domains like emergency medicine.[3]
Mabel AI is poised to expand as generative AI matures for niche, high-stakes applications, with trends like edge computing and multimodal translation (voice + text) boosting its edge. Next steps likely include broader language support, integrations with EHR systems, and public sector pilots amid labor shortages.
Its influence could grow by proving AI's role in preserving healthcare's human core—secure, barrier-free dialogue—scaling from ERs to global clinics while competitors grapple with privacy hurdles. This positions Mabel as a quiet leader in language AI's healthcare pivot.
Mabel has raised $2.1M across 2 funding rounds. Most recently, it raised $640K Seed in November 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Nov 1, 2024 | $640K Seed | Partech Ventures, Summit Partners, Stephan Dietrich | |
| Dec 13, 2022 | $1.5M Seed | Incubate Fund, Manu Chandra, Anshu Prasher |